Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic association with response to intravitreal ranibizumab for neovascular age-related macular degeneration in the Han Chinese population.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde - 1 Jan 2013

Yuan Dongqing, Yuan Donglan, Liu Xiaoyi, Yuan Songtao, Xie Ping, Liu Qinghuai

Abstract excerpt

PURPOSE: To investigate a possible association between gene variants and patient response to treatment with intravitreal ranibizumab for neovascular age-related macular degeneration (AMD). METHODS: Visual acuity score (VAS) was recorded at baseline and a subsequent visit at 6 months. Genotypes of 3 polymorphisms in known AMD susceptibility loci (rs1061170 in complement factor H (CFH), rs11200638 in HTRA1 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Angiogenesis Inhibitors
Share to Antibodies, Monoclonal, Humanized
Share to Complement Factor H
Share to High-Temperature Requirement A Serine Peptidase 1
Share to Intravitreal Injections
Share to Vascular Endothelial Growth Factor A
Share to Visual Acuity
Share to Wet Macular Degeneration

Source

Identifiers

PMID: 24080590
DOI: 10.1159/000355068

Genes

HTRA1
CFH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic association with response to intravitreal ranibizumab for neovascular age-related macular degeneration in the Han Chinese population.PMID 24080590Read ↗

CFH Y402H polymorphism and response to intravitreal ranibizumab in Brazilian patients with neovascular age-related macular degeneration.Semantic proximity Read ↗

Association of genetic polymorphisms with response to bevacizumab for neovascular age-related macular degeneration in the Chinese population.Semantic proximity Read ↗

Genetic associations of anti-vascular endothelial growth factor therapy response in age-related macular degeneration: a systematic review and meta-analysis.Semantic proximity Read ↗

VEGF gene polymorphism and response to intravitreal ranibizumab in neovascular age-related macular degeneration.Semantic proximity Read ↗

CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration.Semantic proximity Read ↗

The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab.Semantic proximity Read ↗

Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD.Semantic proximity Read ↗

Genetic factors associated with response to intravitreal ranibizumab in Korean patients with neovascular age-related macular degeneration.Semantic proximity Read ↗

Association between high-risk disease loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration.Semantic proximity Read ↗

Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.Semantic proximity Read ↗

Pharmacogenetic association with early response to intravitreal ranibizumab for age-related macular degeneration in a Korean population.Semantic proximity Read ↗

Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.